Microfluidics Introduces Basic “No Frills” Microfluidizer Processors for Biopharm Industry
Ideal for Pilot Production of Clinical Batches Requiring cGMP - Enhancements Available When Needed
NEWTON, Mass., July 16, 2007 – Microfluidics has introduced a basic M-700 series of Microfluidizer® high-shear fluid processors ideally suited for producing clinical batches and for scaling up to biopharmaceutical pilot production.
The well established M-7125 and M-7250 machines can now be purchased as economical basic standard biopharmaceutical packages, which include a skid mounted pharma-grade feed pump, a sanitary flush diaphragm pressure transducer with digital readout, and written certifications that all product contact surfaces within the machine and feed pump have been passivated, electro-polished and ground to a 20Ra surface finish.
In keeping with cGMP guidelines, each machine comes standard with IQ/OQ documentation, a document turnover package, on-site start-up and training and CE compliance.
As products evolve, myriad options are available that afford flexibility to the Basic package user. Options can be ordered if or when needed. These include pharma-grade heat exchangers, PLC control, temperature sensing with digital readouts, Ultra Clean In Place (UCIP), and motor starter panels.
Coupled with its patented fixed geometry interaction chambers, the M-700 series Microfluidizer processors generate a controlled rate of shear which allows bacterial, plant and mammalian cells to be safely and efficiently disrupted while enabling the highest shear rates of any fluid processor on the market today to achieve the desired product quality for nano-emulsions and nano-dispersions in the least number of passes.
About Microfluidics
Microfluidics, a wholly owned subsidiary of MFIC Corporation, is a supplier of advanced fluid processing equipment and reaction technology for laboratory, pilot scale and manufacturing applications. Microfluidics is a leader in innovative technology and comprehensive solutions for formulations requiring repeatability and for the production of uniformly distributed nanoparticles.
Microfluidics has been a worldwide supplier of Microfluidizer® high shear fluid processing systems to the Biotechnology and Pharmaceutical industries since 1984. As leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market.
Companies seeking to produce difficult-to-formulate products or to find better methods of bio-processing can take advantage of complimentary sample testing at one of three Microfluidics facilities. Visit www.microfluidicscorp.com, email mixinginfo@mfics.com or contact Microfluidics at 800.370.5452 for application information.
CONTACT:
Lauren Purpura
Gray & Rice Public Relations
617-367-0100 ext. 123
lpurpura@gr2000.com
Downloads
20070716-1912-0C275321.jpg
